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Introduction
Patients with end stage renal disease (ESRD) have an extremely high extra renal morbidity and age adjusted mortality compared with the general population in the United States. [1] [2] [3] A number of factors have been identified which predict risk in this patient population, and some of these factors are reasonably powerful at predicting risk. [4] [5] [6] [7] [8] We have previously reported on patient records kept within the United States Renal Data System (USRDS); 9 a number of qualitative and quantitative measurements are presented which can be accessed rather easily from the National Institutes of Health. 10, 11 In our previous study, we found that a neural network approach was not superior to that obtainable with a logistic linear approach at predicting time to death. However, since that report, advances in machine learning have allowed for the relatively easy application of other approaches which might help clinicians estimate mortality risk in this population. For that reason, the following study was performed.
Methods
Files containing de-identified patient records from the USRDS in 2007 were read in the program SAS (version 9.1), SAS Institute Inc., Cary, NC, and exported in a CSV format. Forty-two variables were selected to be used in the analysis based on their potential clinical significance and their wide availability within the USRDS as we had previously reported. 9 All analysis was performed using the open source program R. We used a generalized linear model as our default. 12 In addition, we examined the utility of a support vector machine, 13 decision trees with the RPART package, neural networks (1 hidden layer, feed forward as previously studied (9)), and random forests. 14, 15 The CARET package was used for comparison of the mature models employing 10 K-folds and 3 repeats performed on a training set (5% of total) chosen with different randomization seeds to allow for reproducibility. 16 Other packages within R were used for different specific tasks (e.g., NNet for construction of the neural network, randomForest (RFor) for constructing random forests) 17 as we recently demonstrated with the Modification of Diet with Renal Disease (MDRD) dataset. 18 For these studies, we focused on the categorical output of survival less than six months. This outcome variable was chosen for its clinical relevance to nephrology practice.
Results and Discussion
In the records that were selected for analysis, just over 67 thousand subjects died within the first six months of starting hemodialysis (HD) therapy whereas the remaining 330 thousand subjects survived longer. The data in these two groups are summarized in Table 1 . Those that died early tended to have poorer nutrition as evidenced by a lower serum albumin, serum creatinine (SCr) and body mass index (BMI) (all p<0.01). They also tended to be significantly older (68.3+/15.0 vs 61.3+/-15.8, p<0.01), have a lower prevalence of insulin dependent diabetes (p<0.01) and higher EPO dosages (p<0.01). The prevalence of ischemic heart disease and prevalence of pulmonary disease were both higher in those dying early (both p<0.01). Many of the data were quite similar in the two groups although because of the large numbers involved, statistical significance was noted ( Table 1 ). The high rates of HIV and AIDS reflects the time that these data were obtained; it is quite likely that a more recent data set would have much lower prevalence for HIV and related conditions. .01 *Note that because number of subjects is so high in both groups, confidence intervals around point estimate for prevalence are <<1% for all categorical values. SCr -serum creatinine, BUN -serum urea nitrogen, ALCOH -alcohol dependency, CANCER -cancer present, CARFAIL-cardiac failure, CVA -cerebrovascular accident, HIV -human immunodeficiency virus positive, AIDS -acquired immunodeficiency syndrome present, DRUG -drug dependency, DYYSRYTH-cardiac arrhythmias, EPO -erythropoietin utilization, HYPER -hypertension present, Ischemic Heart Disease present, MI -history of myocardial infarction, NOAMBGUL-not able to ambulate, PERICARD -pericarditis, PULMONpulmonary disease present, PVASC -peripheral vascular disease present, SMOKE -active smoker.
Different machine learning approaches yielded somewhat different fits as assessed by ROC curves (Figure 1, Table 2 ). In general, the best fits were obtained by either the generalized linear model (logistic regression, GLM) or the random forest (RForest) approach with the feed-forward neural network (NNet) just slightly behind. The SVM was next with the decision tree (RPart) least effective. Because the decision tree method was so weak, we did not investigate its predictions further. In contrast to the ROC curves which demonstrated significant differences (Table 2) , the accuracy values obtained by the remaining four methods were remarkably similar although statistical inferiority to the linear model was evidenced by both the SVM and the NNet models. Accuracy achieved by the Rforest was similar to that obtained by the GLM. Sensitivity of the GLM was inferior to that obtained by the SVM and RForest methods whereas specificity of the NNet method was the best. Along those lines the NNet method had the highest positive predictive value (PPV) where the RForest had the highest negative predictive value (NPV). These data are all summarized in Table 3 . Data shown as mean +/-SD of six determinations. PPV -positive predictive value, NPVnegative predictive value. Positive class is "alive > 6 months." ** p<0.01 vs GLM.
The factors that were most important to the models are shown in Table 4 . It is clear that patient age, serum creatinine and serum albumin are important to the different models. Other measurements made it to the top of some of the models but not others. The different models were remarkably consistent with the importance order with which variables were chosen with the different seeds (data not shown). Albumin-serum albumin, Incident Age -age of first ESRD treatment, SCr -serum creatinine, BUN -serum urea nitrogen, EPO -erythropoietin use, Hypertension -presence of hypertension.
As the entire data set had a relative paucity of early deaths, we examined how our algorithms performed with a balanced training set constructed from drawing from a subpopulation where the fraction of patients with early (< 6 month) deaths was 50:50. When we did this, all training algorithms had dramatic increases in kappa values (to about 0.2) as well as specificity values (to between 0.60 and 0.65) with marked decreases in sensitivity to be essentially matched to the specificity value obtained with that algorithm. As accuracy also decreased by about 20%, we chose to leave the training dataset unbalanced. Manuscripts addressing the challenge of unbalanced data sets recognize this problem but do not offer a universal solution. 19 The results we observed were not very surprising based on our previous experience with this data set where we saw that the neural network model did not afford advantages over linear or actuarial strategies at predicting time to death. 9 In the current study, the logistic linear model (as we were predicting a categorical outcome) was, to all intents and purposes, comparable or superior to more sophisticated strategies at predicting early death after the initiation of dialysis therapy. Cross talk between variables clearly wasn't all that important in the determination of this important outcome; evidence strongly supported the contention that a logistic linear model captured most of the information present in this large data set.
In the analysis performed, sensitivity was calculated based on the model's ability to predict survival. Along with the high prevalence of survivors, the positive predictive value was generally in excess of 80%. This seems to be more than high enough to merit a trial of dialytic therapy. In contrast, the negative predictive value of the models hovered around 50%. Frankly, this does not come close to meeting the authors' threshold for futility of care, and it would seem irresponsible to withhold dialytic therapy for such a prediction. However, it seems that such a prediction might be of a precision sufficient to recommend additional vigilance in monitoring. With the ease of implementing the logistic linear model, this seems to be a reasonable approach based on the data used in this study which are readily available from routine clinical records (and usually submitted with the CMS-2728-U3 form).
